Skip to content
ESSA Pharma
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisors
    • Careers
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Androgen Receptor
    • Aniten Compounds
    • Publications
  • News
  • Investors
    • Investor Info
    • Corporate Governance
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Investor Contact
    • Publications
    • SEC Regulatory Filings
  • Contact
ESSA PHARMA, INC. HAS BEGUN DEVELOPMENT OF A SECOND GENERATION ANITEN COMPOUND FOR THE TREATMENT OF HORMONE-DRIVEN CANCER

News

News Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Date Title
February 11, 2021

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020

January 13, 2021

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer

December 15, 2020

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020

November 25, 2020

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

November 10, 2020

ESSA Pharma to Participate in Upcoming Investor Conferences

October 26, 2020

ESSA Pharma Inc. Announce the Delisting from the TSX-V

October 24, 2020

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

October 19, 2020

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

September 21, 2020

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

  • «
  • 1
  • 2
  • 3
  • 4
  • …
  • 14
  • »
  • Home
  • Our Company
  • Executive Team
  • Board of Directors
  • Scientific Advisors
  • Careers
  • Pipeline
  • Expanded Access Policy
  • Androgen Receptor
  • Aniten Compounds
  • Publications
  • News
  • Press Releases
  • Investors
  • Corporate Governance
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Investor Contact
  • Contact
  • Locations & Inquiries
© ESSA Pharma, Inc. 2020. All rights reserved. Privacy Policy | Terms & Conditions | Code of Conduct